Zhuo, Zhizheng
Li, Yongmei
Duan, Yunyun
Cao, Guanmei
Zheng, Fenglian
Ding, Jinli
Tian, Decai
Wang, Xinli
Wang, Jinhui
Zhang, Xinghu
Li, Kuncheng
Zhou, Fuqing
Huang, Muhua
Li, Yuxin
Li, Haiqing
Zeng, Chun
Zhang, Ningnannan
Sun, Jie
Yu, Chunshui
Han, Xuemei
Haller, Sven
Barkhof, Frederik
Shi, Fudong
Liu, Yaou
Funding for this research was provided by:
Beijing Natural Science fund (7133244)
National Natural Science Foundation of China (81571631, 81870958)
Article History
Received: 17 October 2020
Revised: 8 December 2020
Accepted: 16 December 2020
First Online: 2 January 2021
Compliance with ethical standards
:
: Frederik Barkhof acts as a consultant for Apitope, Bayer-Schering, Biogen-Idec, GeNeuro, Sanofi-Genzyme, Ixico, Janssen Research, Merck-Serono, Novartis, Roche and TEVA. He has received grants, or grants are pending, from the Amyloid Imaging to Prevent Alzheimer’s Disease (AMYPAD) initiative, the Biomedical Research Centre at University College London Hospitals, the Dutch MS Society, ECTRIMS–MAGNIMS, EU-H2020, the Dutch Research Council (NWO), the UK MS Society, and the National Institute for Health Research, University College London. He has received payments for the development of educational presentations from Ixico and to his institution from Biogen-Idec. He is on the editorial board of Radiology, Brain, European Radiology, Multiple Sclerosis Journal and Neurology. None of the other authors declare a relevant conflict of interest.